Comment: Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia [4]

Annals of Pharmacotherapy

Volumn 31, Issue 9, 1997, Pages 1094-1095

  Finkelstein, S N ^a   Huber, S L ^a   Greenberg, P E ^a   Sullivan, S D ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HUMAN; LETTER; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0030828383     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100927     Document Type: Letter

References (6)